If you can please clarify:

1) which vaccine are you specifically talking about that was tested in Brazil.

2) Efficacy was evaluated how many days after dose 2.

3) was this a randomized RCT and was the placebo group maintained as placebo?

4) how long were the participants followed for and what was the rate of breakthrough cases?

--

--

--

Dr. Aditi Bhargava is a molecular neuroendocrinologist with research focus on sex differences in stress biology and immunology.

Love podcasts or audiobooks? Learn on the go with our new app.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Aditi Bhargava

Aditi Bhargava

Dr. Aditi Bhargava is a molecular neuroendocrinologist with research focus on sex differences in stress biology and immunology.

More from Medium

My Mayberry existence — once upon a time

Paul Sanderson: Immune response

Hello friends & family of Janet,

Genes Like Never Before